CircMVP promotes METTL3 activation mediated CTNNB1 m6A modification in the inhibition of colorectal cancer in B7-H3 dependence antitumor immunity
Fang Wang, Qian Wang, Yongfeng Wu, Zebo Huang, Xincao Zhong, Hunan Wang, Yang Chen, Yan Qin, Xiaowei Qi, Xiaosong Ge, Yong Mao
Abstract
models. CircMVP mediated CTNNB1 m6A modification by promoting METTL3 activation and inhibited B7-H3-dependent anti-tumor immune response in CRC. In conclusion, circMVP may be a predictor of CRC immune evasion and a potential therapeutic target.
Topics & Concepts
Colorectal cancerImmunityCancer researchCancerMedicineBiologyChemistryImmunologyImmune systemInternal medicineRNA modifications and cancerCircular RNAs in diseasesPeptidase Inhibition and Analysis